Prime Medicine PRME Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$201.14M-2.7% | -$195.88M+1.1% | -$198.13M-62.6% | -$121.82M+26.3% | ||
| $7.32M+19.5% | $6.13M+31.7% | $4.65M+109% | $2.22M— | ||
| $29.27M+12.3% | $26.07M+87.4% | $13.91M+115% | $6.46M— | ||
| —— | —— | —— | —— | ||
| —— | —— | $9.14M— | —— | ||
| —— | —— | —— | —— | ||
| -$4.55M-128% | $16.13M+70.6% | $9.46M+444% | $1.74M— | ||
| -$4.36M-106% | $71.92M— | —— | —— | ||
| $432K— | —— | —— | —— | ||
| $9.7M-21.5% | $12.36M-3.4% | $12.79M+30.6% | $9.79M— | ||
| -$5.36M+17.0% | -$6.46M-133% | -$2.77M+73.0% | -$10.25M— | ||
| -$162.56M— | —— | -$165.41M-25.5% | -$131.83M— | ||
| $4.53M-37.9% | $7.29M-16.4% | $8.72M-45.8% | $16.1M— | ||
| $205.41M— | —— | $104.96M-14.9% | $123.34M— | ||
| —— | $0-100% | $132.56M+42.5% | $93M— | ||
| —— | $68.46M+266% | $18.71M+140% | -$47.1M+36.0% | ||
| $0— | —— | $0-100% | $219K— | ||
| $151.51M-22.6% | $195.88M+29,805% | $655K-99.6% | $181.49M-32.6% | ||
| —— | —— | -$146.05M-5,781% | $2.57M-98.4% | ||
| $1.94M-37.4% | $3.09M— | —— | —— | ||
| —— | —— | —— | —— | ||
| -$5.36M+17.0% | -$6.46M-133% | -$2.77M+73.0% | -$10.25M— | ||
| -$4.55M-128% | $16.13M+70.6% | $9.46M+444% | $1.74M— | ||
| $9.7M-21.5% | $12.36M-3.4% | $12.79M+30.6% | $9.79M— | ||
| $0+100% | -$1M-688% | $170K— | —— | ||
| $205.41M— | —— | $104.96M-14.9% | $123.34M— | ||
| $95.78M-53.1% | $204.2M+54.0% | $132.56M+42.5% | $93M— | ||
| —— | —— | $0— | —— | ||
| —— | —— | —— | —— | ||
| -$4.36M-106% | $71.92M— | —— | —— | ||
| -$5.36M+17.0% | -$6.46M-133% | -$2.77M+73.0% | -$10.25M— | ||
| —— | —— | —— | —— | ||
| —— | $0-100% | $6.08M— | —— | ||
| $10.91M— | $0— | —— | —— | ||
| -$167.1M— | —— | -$174.14M-17.7% | -$147.92M— | ||
| -$167.1M— | —— | -$174.14M-17.7% | -$147.92M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Prime Medicine generate?
- Prime Medicine (PRME) generated -$156.4M in operating cash flow over the trailing twelve months.
- What is Prime Medicine's free cash flow?
- After $2.3M of capital expenditures, Prime Medicine's free cash flow was -$158.7M over the trailing twelve months, up 19.0% year over year.
- Where does Prime Medicine's cash flow data come from?
- Every line is extracted from Prime Medicine's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
